WinRho® SDF* [Rho (D) Immune Globulin (Human) for Injection]
SDF, [Rho(D) Immune Globulin (Human) for Injection], Cangene’s flagship product, is sold worldwide and is available either as a liquid formulation or a freeze-dried powder.
SDF is known as an anti-D product and is approved for two distinct indications.
SDF was developed in 1968 by renowned pediatric researchers, Drs. Bruce Chown and John (Jack) Bowman. These physicians gained global recognition as pioneers for treating hemolytic disease of the newborn. In appreciation of their achievements, both physicians were made Officers of the Order of Canada.
If you are a U.S. resident or a U.S. healthcare professional, please visit www.winrho.com
*Product Information based on Canadian Product Monograph
The following information is available in Adobe Acrobat
Canadian Product Monographs:
WinRho® SDF Product Inquiries
Tel: 1-877-CANGENE (226-4363)
Tel: 1-800-4WinRho (494-6746)
Tel: 01 (204) 275-4178
Cangene Medical Affairs